Erythropoiesis-stimulating agents in gynecological malignancies: A study-level meta-analysis

This meta-analysis, even if limited by few RCTs, suggests that ESAs reduce transfusions without increasing mortality or disease progression in gynecological cancer patients receiving treatment.